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the keenest delight when I first read of 
the actions of icebergs in transporting 
boulders, and I gloried in the progress 
of geology,” wrote Darwin.
In the afternoon a special birthday 
party will featuring a birthday cake with 
200 candles, attended by children who 
share Darwin’s birthday.
Throughout the year, a series of 
lectures and workshops is planned 
with a range of distinguished guests, 
including a performance by the Rambert 
Dance Company. A new sculpture ‘The 
Quantum Leap’ will also be unveiled 
to represent Darwin’s ground-breaking 
ideas.
In the longer term, the Darwin 
Birthplace Trust has drawn up plans to 
acquire The Mount and transform the 
ground floor rooms, outbuildings and 
courtyard into an interpretation centre. 
This year will see a major fundraising 
effort by the trust to secure the property 
and help further broaden Darwin’s base 
in Britain’s scientific and intellectual 
heritage.
At school: The statue erected outside Darwin’s school, now a library, in his home town, 
Shrewsbury. (Photo: Shrewsbury and Atcham Borough Council.)Sometime in 2006, our household in 
the UK received two letters in the post, 
informing us that appointments had 
been made for us at a local centre 
for our sample donation to the UK 
Biobank. Taken aback by the way our 
participation was taken for granted and 
by the shortage of information on the 
benefits and risks of participating, we 
ended up ignoring the request and have 
never heard from the Biobank again. 
It now turns out that we did provide 
the Biobank project with information 
and became part of its statistics. From 
the pilot phase, of which we were part, 
the organisers learned that only one 
in ten UK residents they approached 
actually turned up to donate their 
samples and medical records. As the 
project aims to collect blood and DNA 
samples and essential health data from 
a total of 500,000 people in the UK, 
this means that they have to approach 
more than five million potential donors.
Large-scale biomedical 
database projects covering 
entire populations have been 
plagued by ethical misgivings  
from the early days of the 
ambitious nationwide projects 
in Estonia and Iceland
The project was rolled out across 
the UK in September 2007 and 
by April 2008 had found 100,000 
participants, suggesting that it may 
take around three years to reach that 
target. As of January 20 this year, the 
head count stands at 245,192, just 
short of the halfway mark.
Large-scale biomedical database 
projects covering entire populations 
have been plagued by ethical 
misgivings from the early days of 
the ambitious nationwide projects 
in Estonia and Iceland (Curr. Biol. 
(2001) 11, R1). Recent cases of 
embarrassing data losses from 
A new planned biomedical databank 
in the US will need to win the 
confidence of potential contributors to 
succeed. Michael Gross reports.
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will not make it easier to convince 
potential participants that datasets 
containing their entire life story, 
medical condition, and DNA profile, 
due to be kept and updated for 
25 years, will be safe from misuse. 
Moreover, the benefit of such large-
scale studies is to be found in highly 
abstract areas of medical science 
such as pharmacogenomics, which 
are difficult to explain to the general 
public, even if they contribute to the 
prevention of common conditions like 
heart disease and cancer in the long 
term. 
The situation is somewhat more 
favourable in the case of rare 
diseases (also referred to as ‘orphan 
diseases’), defined by the European 
Commission as life-threatening or 
chronically debilitating diseases with a 
prevalence of less than five in 10,000. 
In this context, only a limited number 
of patients and their relatives are 
required and indeed eligible to donate 
samples, and the benefit for them is direct and immediately obvious. As 
many of these diseases have been 
neglected by medical research and 
drug development, patients and their 
families have a strong motivation to 
support research wherever they can. 
This is why the EuroBioBank, a 
network of 15 institutions from seven 
European countries, is having much 
less difficulty recruiting the donors 
it needs. The organisation was in 
fact established by two patient 
organisations, namely the Muscular 
Dystrophy Association of France and 
the European Organisation for Rare 
Diseases. 
With funding from the European 
Commission (2003–2006), the project 
has grown rapidly and now contains 
some 170,000 samples — 544 DNA 
collections and 282 tissue collections. 
Its ethical guidelines, consent forms, 
and the selected projects that make 
use of the datasets are all laid open 
on their website. 
Meanwhile, a large healthcare 
provider based in California, Kaiser Permanente, has also started its 
own biobank project, the “research 
program on genes, environment and 
health”. In December 2008, it won 
a grant worth $8.6 million from the 
Robert Wood Johnson Foundation 
to get the project started. It has also 
received other significant grants in 
connection with the project, including 
one of over $12 million from the 
National Institute of Mental Health to 
study the genetics of bipolar disorder 
using the biobank. Like the UK 
national Biobank, it aims at 500,000 
participants, to be recruited from 
its 3.3 million members in Northern 
California by 2012. One of the key 
selling points of the project is that this 
population mirrors the ethnic diversity 
of the US as a whole. 
Kaiser wants to combine medical, 
genetic, and environmental 
information to enable researchers 
to identify even subtle influences 
on disease patterns. The company 
already has some experience in 
large biomedical studies among 
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contributed to the withdrawal of the 
arthritis drug Vioxx. 
With this track record, and the 
option to bank on some degree 
of community spirit among its If life were found elsewhere in our 
universe, what do you suppose the 
odds are that NASA would announce 
it in the form of news release titled, 
“NASA Science Update to Discuss 
Mars Atmosphere Activity”?
Well, from that press release, the 
British tabloid The Sun deduced that 
NASA had found life on Mars.
No matter that the 12 January 
advisory went on to say the embargoed
discovery “raises the possibility of life 
or geologic activity”. Apparently the 
editor of The Sun got tired of reading 
after the word “life.” It would be cynical 
Mediawatch: Richard F. Harris 
looks at press reaction to NASA’s 
announcement of methane bursts on 
Mars.
Darth vapour
Methane mystery: Evidence that pulses of memembership, Kaiser Permanente may 
find it easier to gain the trust of the 
target population than the UK Biobank 
did. They also may want to find a 
different name for the project, for who 
would trust a bank these days? 
to suggest that The Sun simply wanted 
to sell a lot of papers with a screaming 
headline.
So, as we all know, there’s life on 
Mars. Or not. The Sunday Times of 
London had good fun with this. 
“The Sun last week revealed 
that there really is life on Mars, and 
whatever’s up there has terrible wind. 
‘Alien microbes living just below the 
Martian soil are responsible for a haze 
of methane around the Red Planet, 
scientists believe,’ the paper reported. 
‘The gas, belched in vast quantities 
in our world by cows, was detected 
by orbiting spacecraft and from Earth 
using giant telescopes. The find is 
seen as exciting evidence that Martian 
microbes are still alive today.’ ”
The obvious tie-in was with a windmill 
in Lincolnshire, which had been 
damaged by some unknown object. Of 
course, the Sun had sent a reporter out 
thane have been detected on Mars attracted press intMichael Gross is a science writer based at 
Oxford. He can be contacted via his web 
page at www.michaelgross.co.uk
http://www.ukbiobank.ac.uk/
http://www.eurobiobank.org/
http://www.dor.kaiser.org/studies/rpgeh/there to see if UFOs had done the deed. 
The Sun found no sign of alien life.
“Of course not,” The Sunday Times 
said. “They’ll be back home on Mars by 
now, warming their little microbe toes 
against a roasting fire, laughing their 
little microbe heads off, and wondering 
if there is intelligent life on Earth.”
Putting aside the question of whether 
Earthlings are intelligent, the journalists 
at least know a good story when they 
see one. Life on Mars is a sure hit. As 
the Christian Science Monitor put it: 
“Mars looks like it’s reading from a 
Monty Python script: ‘Oi’m not dead 
yet; Oi’m getting bettah.’ Planetary 
scientists announced on Thursday that 
they’ve found three regions on the red 
planet that have pumped methane into 
the Martian atmosphere.”
Or, here’s slightly more sedate lead 
from the New York Times: “In early 
2003, a plume of methane gas rose 
erest. (Photo; NASA/JPL/Science Photolibrary.)
